Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Beam Therapeutics (BEAM)

(Delayed Data from NSDQ)

$22.94 USD

-0.10 (-0.43%)

Updated Jun 21, 2024 04:00 PM ET

After-Market: $22.94 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth A Momentum F VGM

Industry Rank:

Top 35% (86 out of 249)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

View Cart/Checkout

Beam Therapeutics Inc. [BEAM]

Reports for Purchase

Showing records 81 - 100 ( 120 total )

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 81

07/01/2021

Pages: 11

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 82

07/01/2021

Industry Report

Pages: 20

The Wedbush Monthly Check-Up: July 2021

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 83

07/01/2021

Pages: 5

The ABC?s: APLS, BEAM, and C3

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 84

06/29/2021

Pages: 7

BEAMing Across Indications

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 85

06/29/2021

Pages: 4

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 86

05/12/2021

Pages: 16

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 87

05/11/2021

Pages: 6

These LNPs Deliver

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 88

04/28/2021

Industry Report

Pages: 13

ASGCT 2021 Virtual Meeting Abstract Review

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 89

04/21/2021

Pages: 9

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 90

04/20/2021

Pages: 8

Base Editing And More

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 91

03/15/2021

Pages: 5

BEAM Focusing on Its IND Submission

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 92

02/25/2021

Pages: 15

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 93

02/24/2021

Pages: 7

Delivery Is Easier with a Guide

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 94

02/16/2021

Industry Report

Pages: 7

Biotechnology -Apres BLUE, Lenti Deluge

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 95

12/11/2020

Industry Report

Pages: 24

ASH 2020 Roundup for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 96

11/13/2020

Pages: 4

On the Beam in GSD1a

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 97

11/11/2020

Pages: 12

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 98

11/10/2020

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 99

11/10/2020

Pages: 6

BEAM-201 Development Candidate--Allo Cell Therapy for TALL

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Beam Therapeutics Inc.

Industry: Medical - Biomedical and Genetics

Record: 100

11/10/2020

Pages: 16

SITC 2020 Abstract Preview for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party